ArticleBMC health services research2019

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies.

Michal Pochopien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.